Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents

AIM: To evaluate the outcomes in biological treatment and quality of life of psoriatic patients with chronic hepatitis C (CHC) treated with new Direct-Acting Antiviral agents (DAAs) compared to pegylated interferon-2α plus ribavirin (P/R) therapy. METHODS: This is a retrospective study involving pso...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Hepatol
Main Authors: Damiani, Giovanni, Franchi, Chiara, Pigatto, Paolo, Altomare, Andrea, Pacifico, Alessia, Petrou, Stephen, Leone, Sebastiano, Pace, Maria Caterina, Fiore, Marco
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2018
Assuntos:
Observational Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838451/
https://ncbi.nlm.nih.gov/pubmed/29527268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i2.329
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados